Advertisement
Singapore markets open in 2 hours 8 minutes
  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     
  • S&P 500

    5,267.84
    -39.17 (-0.74%)
     
  • Dow

    39,065.26
    -605.78 (-1.53%)
     
  • Nasdaq

    16,736.03
    -65.51 (-0.39%)
     
  • Bitcoin USD

    67,537.59
    -1,560.38 (-2.26%)
     
  • CMC Crypto 200

    1,468.00
    -34.66 (-2.31%)
     
  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     
  • Gold

    2,332.10
    -5.10 (-0.22%)
     
  • Crude Oil

    76.91
    +0.04 (+0.05%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

Oscar Health, Kenvue, Hims & Hers: Health earnings roundup

Yahoo Finance Health Reporter Anjalee Khemlani joins Wealth! to analyze this morning's round of earnings out from top health companies, including health insurance provider Oscar Health (OSCR), consumer health product maker Kenvue (KVUE), and telehealth distributor Hims & Hers Health (HIMS).

Most notably, Oscar Health reported a profitable quarter as it saw enrollment figures rise. Kenvue's stock is moving higher Tuesday morning while also announcing plans to layoff 4% of its workforce. Ahead of reporting earnings, Hims & Hers CEO Andrew Dudum has weighed in on the Israel-Palestine conflict and recent college protests on social media.l

For more expert insight and the latest market action, click here to watch this full episode of Wealth!

This post was written by Luke Carberry Mogan.